Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent

被引:20
|
作者
Turco, Simona [1 ]
Tardy, Isabelle [2 ]
Frinking, Peter [2 ]
Wijkstra, Hessel [3 ]
Mischi, Massimo [1 ]
机构
[1] Eindhoven Univ Technol, Dept Elect Engn, Groene Loper 19, NL-5600 MB Eindhoven, Netherlands
[2] BRACCO SUISSE SA, Route Galaise 31, CH-1228 Geneva, Switzerland
[3] Acad Med Ctr, Dept Urol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
来源
PHYSICS IN MEDICINE AND BIOLOGY | 2017年 / 62卷 / 06期
基金
欧洲研究理事会;
关键词
molecular imaging; contrast-enhanced ultrasound; angiogenesis; targeted microbubbles; pharmacokinetic modeling; ACOUSTIC RADIATION FORCE; ANTIANGIOGENIC THERAPY; TUMOR ANGIOGENESIS; FUTURE-DIRECTIONS; PROSTATE-CANCER; MICROBUBBLES; DISPERSION; BR55; LOCALIZATION; GROWTH;
D O I
10.1088/1361-6560/aa5e9a
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Ultrasound molecular imaging (USMI) is an emerging technique to monitor diseases at the molecular level by the use of novel targeted ultrasound contrast agents (tUCA). These consist of microbubbles functionalized with targeting ligands with high-affinity for molecular markers of specific disease processes, such as cancer-related angiogenesis. Among the molecular markers of angiogenesis, the vascular endothelial growth factor receptor 2 (VEGFR2) is recognized to play a major role. In response, the clinical-grade tUCA BR55 was recently developed, consisting of VEGFR2-targeting microbubbles which can flow through the entire circulation and accumulate where VEGFR2 is over-expressed, thus causing selective enhancement in areas of active angiogenesis. Discrimination between bound and free microbubbles is crucial to assess cancer angiogenesis. Currently, this is done non-quantitatively by looking at the late enhancement, about 10 min after injection, or by calculation of the differential targeted enhancement, requiring the application of a high-pressure ultrasound (US) burst to destroy all the microbubbles in the acoustic field and isolate the signal coming only from bound microbubbles. In this work, we propose a novel method based on mathematical modeling of the binding kinetics during the tUCA first pass, thus reducing the acquisition time and with no need for a destructive US burst. Fitting time-intensity curves measured with USMI by the proposed model enables the assessment of cancer angiogenesis at both the vascular and molecular levels. This is achieved by estimation of quantitative parameters related to the microvascular architecture and microbubble binding. The proposed method was tested in 11 prostate-tumor bearing rats by performing USMI after injection of BR55, and showed good agreement with current USMI methods. The novel information provided by the proposed method, possibly combined with the current non-quantitative methods, may bring deeper insight into cancer angiogenesis, and thus potentially improve cancer diagnosis and management.
引用
收藏
页码:2449 / 2464
页数:16
相关论文
共 50 条
  • [41] Fabrication of targeted gold nanoparticle as potential contrast agent in molecular CT imaging
    Malekzadeh, Reza
    Ghorbani, Marjan
    Faghani, Parsa
    Abdollahi, Behnaz Babaye
    Mortezazadeh, Tohid
    Farhood, Bagher
    JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES, 2023, 16 (01)
  • [42] CRITICAL APPRAISAL OF TARGETED ULTRASOUND CONTRAST AGENTS FOR MOLECULAR IMAGING IN LARGE ARTERIES
    Kornmann, Liselotte M.
    Reesink, Koen D.
    Reneman, Robert S.
    Hoeks, Arnold P. G.
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2010, 36 (02): : 181 - 191
  • [43] Molecular imaging of atherosclerotic plaque with lipid nanobubbles as targeted ultrasound contrast agents
    Zhang, Xiangyu
    Wu, Mingcong
    Zhang, Yu
    Zhang, Jie
    Su, Jin
    Yang, Chunrong
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2020, 189 (189)
  • [44] Ultrasound Molecular Imaging of Angiogenesis Using alphavbeta3 Integrin-targeted Bubbles Based on a Clinically Available Ultrasound Contrast Agent
    Otani, Kentaro
    Nishimura, Hirohito
    Kamiya, Atsunori
    Harada-Shiba, Mariko
    CIRCULATION, 2017, 136
  • [45] Sentinel Lymph Node Characterization with a Dual-Targeted Molecular Ultrasound Contrast Agent
    Nam, Kibo
    Stanczak, Maria
    Forsberg, Flemming
    Liu, Ji-Bin
    Eisenbrey, John R.
    Solomides, Charalambos C.
    Lyshchik, Andrej
    MOLECULAR IMAGING AND BIOLOGY, 2018, 20 (02) : 221 - 229
  • [46] Sentinel Lymph Node Characterization with a Dual-Targeted Molecular Ultrasound Contrast Agent
    Kibo Nam
    Maria Stanczak
    Flemming Forsberg
    Ji-Bin Liu
    John R. Eisenbrey
    Charalambos C. Solomides
    Andrej Lyshchik
    Molecular Imaging and Biology, 2018, 20 : 221 - 229
  • [47] Optimization of ultrasound contrast agent for high frequency ultrasound molecular imaging using subharmonic oscillation
    Daeichin, V.
    Kooiman, K.
    Skachkov, I.
    Bosch, J. G.
    van der Steen, A. F. W.
    de Jong, N.
    2014 IEEE INTERNATIONAL ULTRASONICS SYMPOSIUM (IUS), 2014, : 1766 - 1769
  • [48] DESIGN OF A PARAMAGNETIC CONTRAST IMAGING AGENT THROUGH THE USE OF MOLECULAR MODELING
    BURNS, TP
    MERCERSMITH, JA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 418 - INOR
  • [49] Targeted imaging using ultrasound contrast agents
    Bloch, SH
    Dayton, PA
    Ferrara, KW
    IEEE ENGINEERING IN MEDICINE AND BIOLOGY MAGAZINE, 2004, 23 (05): : 18 - 29
  • [50] Ultrasound Contrast Agents For Ultrasound Molecular Imaging
    Tranquart, F.
    Arditi, M.
    Bettinger, T.
    Frinking, P.
    Hyvelin, J. M.
    Nunn, A.
    Pochon, S.
    Tardy, I.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (11): : 1268 - 1276